The enteral nutrition market has seen considerable growth due to a variety of factors.
•The market size of enteral nutrition has experienced significant growth in the past few years. It is projected to expand from $12.44 billion in 2024 to $13.38 billion in 2025, translating to a compound annual growth rate (CAGR) of 7.6%.
The expansion in the historic period can be credited to clinical demand, hospital and clinical conditions, surgical operations, enhanced feeding tubes, and heightened awareness.
The enteral nutrition market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market size of enteral nutrition is anticipated to experience substantial growth, with projections estimating it will reach a value of $18.35 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.2%.
Factors such as patient-oriented care, chronic health issues, home-based care, customized nutrition, and an increase in gastrointestinal disorders can be credited for this projected growth during the forecast period. Key trends expected to emerge during this period include the refining of administration methods, advancement in tube placement technologies, the creation of modular and bespoke nutrition solutions, development in immunonutrition, and the availability of home enteral feeding kits.
The rise in chronic illnesses is projected to boost the enteral nutrition market. Chronic or non-communicable diseases (NCDs), which develop slowly and last for a significant amount of time, include ailments like cardiovascular diseases, diabetes, respiratory illnesses, cancer, chronic kidney issues, neurological disorders, rheumatoid arthritis, and other autoimmune diseases. Enteral nutrition may assist patients struggling with eating or maintaining sufficient nutrition due to their disease or its treatments. For example, a report from the American Cancer Society, Inc., a nationwide US health organization focused on eradicating cancer, showed that the number of new liver cancer cases in women diagnosed in the US rose from 12,660 in 2022 to 13,230 in 2023. Moreover, statistics released by the International Diabetes Federation, a non-profit diabetes association based in Belgium, revealed that in 2021, 537 million adults aged 20-79 were living with diabetes, with the disease claiming 6.7 million lives. By 2030, the number of people with diabetes worldwide is expected to reach 643 million. Consequently, the surge in the prevalence of chronic illnesses is propelling the enteral nutrition market.
The enteral nutrition market covered in this report is segmented –
1) By Product Type: Standard Enteral Nutrition, Enteral Nutrition For Chronic Illness
2) By Nutrition Type: Proteins, Carbohydrates, Multi Vitamins, Antioxidants, Amino Acids, Fibers, Minerals, Other Nutritional Types
3) By Patient Type: Adults, Pediatric
4) By Application: Cancer, Critical Care, Diabetes, Gastrointestinal Diseases, Other Applications
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Standard Enteral Nutrition: Polymeric Formulas, Oligomeric Formulas, Blenderized Or Whole Food Formulas
2) By Enteral Nutrition For Chronic Illness: Disease-Specific Formulas, High-Protein Formulas, Specialized Formulas
A rising trend in the enteral nutrition market is product innovation. To solidify their standing in the sector, leading enterprises are focusing on formulating technologically advanced and innovative solutions. For example, VGM Wound Care, a UK-based healthcare provider and vendor resource and community center with a specialization in wound care, rolled out the Enteral Nutrition Guide in August 2023. This thorough resource, specifically designed for integrating enteral nutrition into a wound care business of HME providers, provides critical instructions, protocols, and guidance. The guide, by VGM Wound Care, is a marked step forward for wound care businesses seeking to enhance patient care and diversify their services. Complete with extensive information and guidance, this resource offers HME providers the tools needed to smoothly integrate enteral nutrition into their wound care provisions.
Major companies operating in the enteral nutrition market include:
• Cardinal Health Inc.
• Nestle S.A.
• Fresenius Kabi AG
• Abbott Laboratories
• Medtronic Inc.
• Danone S.A.
• Becton
• Dickinson and Company
• Otsuka Pharmaceutical Factory
• Boston Scientific Corporation
• Hormel Foods Corporation
• B. Braun Melsungen AG
• Reckitt Benckiser Group PLC
• Meiji Holdings Co. Ltd.
• C. R. Bard GmbH
• Moog Inc.
• Mead Johnson Nutrition
• Cook Medical
• Halyard Health Inc.
• Avanos Medical Inc.
• Applied Medical
• Angiplast Pvt Ltd.
• Kate Farms
• Global Health Products Inc.
• Victus Inc.
• VYGON SAS
North America was the largest region in the enteral nutrition market in 2024. The regions covered in the enteral nutrition market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.